Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

S100A3 protein is crucial for hair shaft formation in mice.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Women with hair loss had lower IGF-1 levels.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.